Reporting owner · CIK 0001766850

Kiai Parsa

SEC Form 4 history across 1 companies, 8 transactions and 3 filings.

DIRMEDIFAST INC
Open-market transaction mix100% buys8 buys · 0 sales

Available history · Aug 19, 2026 – Aug 26, 2026

Filings3Form 4 records
Buying$1.4M8 purchases
Selling$00 sales
Net value$1.4MBuys minus sells · disclosed values

Latest insider transactions

Form 4 filings from available history.
Kiai Parsa transactions · 20 per page
CompanyInsiderActivityDisclosed valueFiled (ET)
MEDMEDIFAST INC
Kiai ParsaDIRP · buySEC filing ↗$14.4kView disclosure →
MEDMEDIFAST INC
Kiai ParsaDIRP · buySEC filing ↗$514kView disclosure →
MEDMEDIFAST INC
Kiai ParsaDIRP · buySEC filing ↗$1.41kView disclosure →
MEDMEDIFAST INC
Kiai ParsaDIRP · buySEC filing ↗$50.5kView disclosure →
MEDMEDIFAST INC
Kiai ParsaDIRP · buySEC filing ↗$13.6kView disclosure →
MEDMEDIFAST INC
Kiai ParsaDIRP · buySEC filing ↗$487kView disclosure →
MEDMEDIFAST INC
Kiai ParsaDIRP · buySEC filing ↗$9.31kView disclosure →
MEDMEDIFAST INC
Kiai ParsaDIRP · buySEC filing ↗$332kView disclosure →

Latest Form 4 facts

Quick context from source filings

Latest open-market transaction

buy at MEDIFAST INC on Aug 26, 2026 valued at $14,409.

Review SEC filing
Latest sale

No open-market insider sale is available.

Monthly open-market activity

Last 1 reported months · purchases and sales

View exact monthly values
Monthly open-market source values
MonthPurchasesSalesBuy valueSale valueNet value
Aug 202680$1,423,802.02$0.00$1,423,802.02

Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.

Ownership and transaction size

Ownership and ticket size

Average P/S size$178K
Median P/S size$32.5K
Direct0
Indirect8
Aug 26, 2026buy

Filing-only signals

Deterministic matches in this insider's history

Associated companies

Companies in the disclosed reporting history

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

No purchases currently have the price observations needed for a 90-day return. This may reflect incomplete price coverage or purchases that have not reached the return window.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

8 observations · Aug 19, 2026 – Aug 26, 2026. Window ends at the latest available report, not today.

Selected observation · Aug 26, 202620,270 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
Aug 19, 2026619,331Aug 21, 2026View transaction
Aug 19, 202617,802Aug 21, 2026View transaction
Aug 20, 2026661,306Aug 21, 2026View transaction
Aug 20, 202618,977Aug 21, 2026View transaction
Aug 24, 2026665,517Aug 26, 2026View transaction
Aug 24, 202619,095Aug 26, 2026View transaction
Aug 26, 2026707,492Aug 28, 2026View transaction
Aug 26, 202620,270Aug 28, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Kiai Parsa Insider Activity FAQ

SEC Form 4 context

Who is Kiai Parsa?

Kiai Parsa is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001766850.

Which companies has Kiai Parsa reported transactions for?

MEDIFAST INC

When was Kiai Parsa's latest insider buy?

buy at MEDIFAST INC on Aug 26, 2026 valued at $14,409.

When was Kiai Parsa's latest insider sale?

No open-market insider sale is available for this period.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.